Join Us for This Live Webinar
Wednesday, September 23, 2026 – 12:00 PM PST | 3:00 PM EST
Optimizing manufacturing performance is critical to the success of cell and gene therapy programs.
In this webinar, we will explore how a structured assessment of materials, process steps, analytical testing workflows, and operational handoffs can uncover actionable opportunities to reduce variability, lower cost per batch, and accelerate timelines. Through real-world examples across multiple therapy types and development stages, you will learn how early operational evaluation and targeted workflow optimization can drive measurable impact.
Attendees will come away with strategies to enable smoother transitions into GMP manufacturing, minimize late-stage process changes, and support consistent, long-term production success.
Key Takeaways:
- How to identify hidden inefficiencies across materials, processes, and testing workflows
- Practical approaches to reducing variability and improving batch consistency
- Strategies to lower cost per batch without compromising quality
- Best practices for enabling seamless transition into GMP manufacturing
- How early operational assessment reduces late-stage risks and delays
Speaker Details:
Speaker: Nithya Jesuraj
Email: Nithya.jesuraj@minaris.com
Job Title: Director, Strategic Marketing, CDMO
Company/Institution: Minaris
Bio: Nithya J. Jesuraj, Ph.D., is Director of Strategic Marketing, CDMO, at Minaris, where she leads strategic growth initiatives to advance cell and gene therapy programs. In her role, she supports the expansion of the CDMO business by aligning technical capabilities with market needs, refining value propositions, and enabling commercial teams with data-driven positioning and customer insights. She focuses on translating complex science into practical commercial strategies that drive customer engagement and long-term growth.
With more than 14 years of experience spanning Resilience, Bio-Techne, and early-stage innovation environments, Dr. Jesuraj has launched multiple breakthrough products and service lines while shaping go-to-market strategy, technology partnerships, and commercial execution. A published scientist and frequent speaker, she combines technical depth with market insight to help organizations differentiate and scale.
She holds a Ph.D. and M.S. in Biomedical Engineering from Washington University in St. Louis and a B.S. in Chemical Engineering from Cornell University.